ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NRO Neurones

45.40
0.40 (0.89%)
31 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Neurones EU:NRO Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 0.89% 45.40 45.05 45.40 45.40 44.75 45.00 15,153 16:35:02

NEURONES: 2012 annual results

27/02/2013 4:43pm

GlobeNewswire


PRESS INFORMATION                        Nanterre, February 27, 2013 (after the closing of the stock exchange)
Heading: 2012 annual results

8.9% operating profit and
€17.2 million net profit in 2012

Accounts as at 31 December
(audited and in millions of euros)
         2012          2011
Revenues 315.4 283.3
Business operating profit *   29.2 (9.3%)   27.1 (9.6%)
Operating profit   28.1 (8.9%)   26.3 (9.3%)
Net financial profit     1.4     2.5
Income tax  (12.3)  (11.8)
Net profit   17.2 (5.4%)   17.0 (6.0%)
  • of which, group share
  14.9   14.8
Net cash and cash equivalents   87.8   75.1
Staff at year-end 3,704 3,471


(*) Prior to cost of free shares, stock options and impairment of assets

Achievements

In a steady market, NEURONES experienced growth of 11.3% in 2012 (including 9.3% internal growth).

Operating profit (*) in 2012 also increased and totaled 8.9% of revenues.

The net profit after tax (rate of 41.7%, including CVAE, a contribution based on businesses' added value) amounted to 5.4%.

The conversion of net profit into cash was satisfactory. The net cash and cash equivalents at year-end stood at €87.8 million (i.e. €3.71 per share).

Goodwill only represents three years of the acquired companies' cash flow overall.

(*) after 0.4% related to the cost of free shares, stock options and impairment of assets.

Outlook

As usual, forecasts for the current year will be posted along with the Group's 1st quarter revenues.

About NEURONES

With over 3,700 experts, the NEURONES group is specialized in Consulting (Management and Organization) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems. The size of the group has doubled over the past five years.

NYSE Euronext: Compartment B - ISIN code: FR0004050250 - NYSE symbol: NRO
www.neurones.net

Press Relations:
Florence Gillier Communication
Frédérique Guillo
Tel.: +33 (0)1 41 18 85 55
fredg@fgcom.fr
NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
rp@neurones.net
Investor relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
investisseurs@neurones.net
NEURONES - 2012 annual results



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: NEURONES via Thomson Reuters ONE

HUG#1681718

1 Year Neurones Chart

1 Year Neurones Chart

1 Month Neurones Chart

1 Month Neurones Chart

Your Recent History

Delayed Upgrade Clock